Company
Last deal
$132.2M
Amount
Post-IPO Equity
Stage
14.06.2021
Date
10
all rounds
$389M
Total amount
General
About Company
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Industry
Sector :
Subsector :
Keywords :
Also Known As
Cytokine Mimetics
founded date
01.01.2001
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
location
Phone number
Website URL